Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2026-05-21 @ 1:40 PM
Study NCT ID:
NCT05104333
Status:
UNKNOWN
Last Update Posted:
2021-11-03
First Post:
2021-10-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes
Sponsor:
China National Biotec Group Company Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
COVAX BOOSTER (HT/DM)-Beijing
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None